<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Publication:
In silico analysis of a de novo OTC variant as a cause of ornithine transcarbamylase deficiency

Loading...
Thumbnail Image

Departments

School / College / Institute

Item type:Organizational Unit,

Program

KU-Authors

Organization Authors

Co-Authors

Ozdemir, Yesim

Cag, Murat

Gul, Seref

Yuksel, Zafer

Ergoren, Mahmut C.

Date

Language

Embargo Status

N/A

Journal Title

Journal ISSN

Volume Title

Alternative Title

Abstract

Ornithine transcarbamylase deficiency (OTCD) is the most common X-linked hereditary disorder of urea cycle disorders that is caused by neonatal hyperammonemia. OTC gene sequence variations are common causes of OTCD. The current study presents a 28-month-old baby girl proband with phenotypical characteristics of OTCD such as irritability, somnolence, intermittent vomiting, and high levels of serum ammonium. Whole-exome sequencing revealed a de novo c.275G > A p. (Arg92Gln) variant within the OTC gene. In silico analysis revealed a possible differential affinity between wild-type and mutant OTCase, while Arg92Gln decreases the binding ability of OTCase to the substrate, which can disrupt the urea cycle and explains the molecular pathogenicity of clinical hyper-ammonemia. In light of the fact that the genotype and phenotype correlation of OTCD is still uncertain, the present in silico analysis outcome can enhance our knowledge on this complicated, rare, and severe genetic disorder.

Source

Publisher

Lippincott Williams and Wilkins

Citation

item.page.haspartof

Source

Applied Immunohistochemistry and Molecular Morphology

item.page.ispartofseries

item.page.edition

DOI

item.page.datauri

item.page.link

Rights

N/A

Copyrights Note

Rights and licensing

N/A

Endorsement

Review

Supplemented By

Referenced By

Related Patent

Related Goal

Google Scholar
Scholar'da Ara ↗
Bu yayında DOI yok — Altmetric/Dimensions/PlumX/BIP! rozetleri DOI gerektirir.